An original vision of AI to cure disease

Our story began in 2016 from the pain of losing two sisters to cancer, the resolve to never again be powerless in the face of disease, and the vision to build custom AI’s to solve the “impossible” bottlenecks of drug discovery. Today, AI drug discovery and RNA-targeted small molecules are still considered intractable. We solved them.

Our vision

Give people more health and more time to achieve their life potential. Do so with the potency of gene therapy yet the convenience and safety of a pill.

Genetic Leap is building paradigm-shifting AI technologies that find the causal factors in intractable disease and correct these factors with precision RNA-targeted drug that is effective, convenient, and safe.

The stage

When there’s an imbalance (disease) in the body’s universe, specific worlds (targets) are to blame. And they must be (1) found and (2) fixed without negative side effects.

At the molecular level, the human body is a vast universe with countless interacting worlds and systems.

100GB size of a single human whole genome

90% is transcribed into non-coding RNA

1% is transcribed into coding RNA that is further translated into proteins

0.001% is addressed by current drugs

The 1st problem

Finding the imbalanced worlds is hard because the body’s universe is extremely vast and noisy.

Current technologies have limited explorers to searching only ~1% of this universe (the exome and proteome). Any effort to go beyond these limits quickly gets disoriented by the vast noise and sucked into the many black holes lurking about.

The solution to 1

Genetics-aware AI that allows venturing into the far reaches of the genome’s greater, secret-holding systems.

Genetic Leap has built technology to resolve the whole genome in full, solving the sample size and noise problems that many have thought impossible. Further, the whole genome-derived causal variants are deep-traced through biomolecular networks to affirm the targets to modulate for a cure.

The 2nd problem

Fixing an imbalanced world traditionally focused on its 3rd dimension (proteins), which has many limitations.

Target worlds have three dimensions: DNA, RNA, and protein. Dimension 3 (proteins) is most popular for intervention because it’s the most accessible, and the intervention is more easily administered and is reversible. But dimension 3 has many issues including the fact that only dimension 1 (DNA) and dimension 2 (RNA) are present in the vast majority of worlds. Further, dimension 3 must have certain properties to be engaged, which even fewer worlds have, i.e., undruggability.

In recent decades, dimension 1 has also seen a lot of excitement with new interventions to directly engage it (e.g., CRISPR). But there are many problems including how to get these interventions to dimension 1 and, even more importantly, the wrong world can be hit and changes are permanent, which would lead to even more unintended imbalances and negative side effects in the universe of the body.

Dimension 2 is versatile like dimension 1 and reversible like dimension 3, but it is the most complex to drug. The very few successful attempts have required gargantuan resources and have proven difficult to reproduce.

The solution to 2

Breakthrough AI technology to reliably and scalably intervene at dimension 2 (RNA).

Our breakthrough RNA-targeting capabilities allow intervention in virtually every target world in the body’s universe. The intervention is precise and powerful like gene therapy against dimension 1, yet convenient and reversible like conventional pills against dimension 3. Either of the RNA’s sequence or structure can be drugged using oligonucleotides and small molecules respectively.

Latest in news